Skip to content
Home/GPs/Singular Capital Partners
Singular Capital Partners

Singular Capital Partners

Paris, France·Founded 2019··singular.vc

Singular Capital Partners is a pan-European venture capital firm founded in October 2019 by Jeremy Uzan and Raffi Kamber, former Alven partners who backed Algolia and OpenClassrooms. SIREN 878956911 AMF GP-20000009 SAS HQ 38 rue des Jeuneurs 75002 Paris with London office since 2023 (Henri Tilloy joined May 2023 as Partner). The firm targets Seed through Series B rounds with a strong Series A emphasis deploying tickets from EUR 1M to EUR 25M per company across all sectors and ten European countries operating as a generalist with no vertical mandate and supporting portfolio companies through dedicated SPVs at Series C and D rather than a dedicated late-stage fund. Singular manages two FPCI vehicles Singular Ventures I (2020 vintage EUR 225M) and Singular Ventures II (2023 vintage EUR 400M) for total commitments above EUR 625M. LPs include Ontario Teachers Pension Plan Bpifrance AXA Venture Partners Sofina MACSF Mubadala Capital and Vintage Investment Partners. Notable exit Quantive May 2025 to WorkBoard Trade Sale.

AUM
€625M
Funds
2
vintages 2020–2023
Portfolio
36
Exits
3
SectorsSoftwareHealthcareConsumerFinancialsIndustrials

Key facts

HQParis, France
Founded2019

Recent exits

FORMEL Skin
Healthcare · 2025 · 4yr hold
Quantive
Software · 2025 · 4yr hold
Chroma
Software · 2024 · 2yr hold

Coverage notes

2 funds tracked, 39 portfolio companies (36 active · 3 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Singular Capital Partners has raised, with its portfolio companies. Hand-checked from public filings.

2 funds
Singular Ventures IIVC
2023 · 3yr€400M22 active

Unrealized

22 held
SoftwareBelgium· Entry 2024
ApohaActive
HealthcareUK· Entry 2026
asap.workActive
SoftwareFrance· Entry 2023
HealthcareUK· Entry 2024
IndustrialsUK· Entry 2023
HeyflowActive
SoftwareGermany· Entry 2024
Life5Active
FinancialsSpain· Entry 2023
LucisActive
HealthcareFrance· Entry 2026
LupaActive
HealthcareUK· Entry 2025
ManualActive
HealthcareUK· Entry 2025
HealthcareFrance· Entry 2024
OrusActive
FinancialsFrance· Entry 2025
Osium AIActive
IndustrialsFrance· Entry 2023
Peec AIActive
SoftwareGermany· Entry 2025
PreludeActive
SoftwareFrance· Entry 2024
QobraActive
SoftwareFrance· Entry 2023
SaturnActive
FinancialsUK· Entry 2025
Spore.BioActive
HealthcareFrance· Entry 2025
SoftwareGermany· Entry 2024
ThynkActive
SoftwareUK· Entry 2023
TsugaActive
SoftwareFrance· Entry 2025
VibeActive
SoftwareUS· Entry 2024
Singular Ventures IVC
2020 · 6yr€225M14 active · 3 realized

Unrealized

14 held
ClimatiqActive
SoftwareGermany· Entry 2022
FairmatActive
IndustrialsFrance· Entry 2021
SoftwareFrance· Entry 2021
IndyActive
SoftwareFrance· Entry 2021
Moka.careActive
HealthcareFrance· Entry 2021
PapierActive
ConsumerUK· Entry 2022
HealthcareGermany· Entry 2022
HealthcareFrance· Entry 2021
SharesActive
FinancialsUK· Entry 2021
SodaActive
SoftwareBelgium· Entry 2021
SpartaActive
FinancialsUK· Entry 2022
TinybirdActive
SoftwareSpain· Entry 2022
TypologyActive
ConsumerFrance· Entry 2020
WethenewActive
ConsumerFrance· Entry 2021

Realized

3 exits
ChromaExited 2024
SoftwareSweden· Entry 2022
Trade Saleto
FORMEL SkinExited 2025
HealthcareGermany· Entry 2021
Trade Saleto
QuantiveExited 2025
SoftwareBulgaria· Entry 2021
Trade Saleto
Track Singular Capital Partners

Saved GPs appear in your watchlist, one click from your workspace.

About Singular Capital Partners

Singular Capital Partners is a French venture capital firm headquartered in Paris with capital deployed across 1 active fund vehicles. Founded in 2019, the firm deploys institutional capital across early-stage and selective growth-stage equity rounds in European technology companies, with sector focus spanning TMT, industrials, software, consumer, healthcare and business services.

Investment thesis

Singular Capital Partners targets European and selectively global early-stage and growth-stage technology companies across TMT, industrials, software, consumer, healthcare and business services, deploying institutional venture capital across seed, Series A and Series B rounds. The firm emphasises hands-on operational support during the post-investment value-creation phase, leveraging founder and operator partners alongside institutional capital to support international expansion and category leadership across France and selectively across Europe. Average equity tickets vary by stage with reserve capital preserved for follow-on rounds across the platform.

Recent activity

Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 1 dedicated investment vehicle, 22 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated July 2026 · Sourced from public filings